Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmel M Hawley

Showing results (1-10 of 321) with videos related to

Pageof 33
Sort By:
Nephrology (Carlton, Vic.)|April 22, 2017
Parathyroid hormone targets in chronic kidney disease and managing severe hyperparathyroidismCarmel M Hawley, Stephen G Holt
Kidney International|July 24, 2019
Identifying geospatial "hot spots" of glomerular diseases: opportunities and challengesCarmel M Hawley, Elaine M Pascoe
Nature Reviews. Nephrology|January 3, 2025
A golden year of innovative kidney disease therapeuticsMonica Suet Ying Ng, Carmel M Hawley
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 25, 2016
Focus on peritoneal dialysis training: working to decrease peritonitis ratesLei Zhang, Carmel M Hawley, David W Johnson
International Journal of Nephrology|June 5, 2014
Clinical causes of inflammation in peritoneal dialysis patientsYeoungjee Cho, Carmel M Hawley, David W Johnson
Expert Review of Endocrinology & Metabolism|July 31, 2018
An update on bone imaging and markers in chronic kidney diseaseRathika Krishnasamy, Carmel M Hawley, David W Johnson
Nephrology (Carlton, Vic.)|May 15, 2007
Is it time to revisit residual renal function in haemodialysis?Tsun G Ng, David W Johnson, Carmel M Hawley
The New England Journal of Medicine|March 11, 2011
Frequent versus standard hemodialysisSunil V Badve, Carmel M Hawley, David W Johnson
Journal of Medical Case Reports|August 20, 2010
Probable tacrolimus toxicity from tibolone co-administration in a woman: a case reportCarolyn J Clark, Carmel M Hawley, David W Mudge
Nephrology (Carlton, Vic.)|January 29, 2011
Is the problem with the vehicle or the destination? Does high-dose ESA or high haemoglobin contribute to poor outcomes in CKD?Sunil V Badve, Carmel M Hawley, David W Johnson
Pageof 33

Showing results (1-10 of 321) with videos related to

Sort By:
Pageof 33
Nephrology (Carlton, Vic.)|April 22, 2017
Parathyroid hormone targets in chronic kidney disease and managing severe hyperparathyroidismCarmel M Hawley, Stephen G Holt
Kidney International|July 24, 2019
Identifying geospatial "hot spots" of glomerular diseases: opportunities and challengesCarmel M Hawley, Elaine M Pascoe
Nature Reviews. Nephrology|January 3, 2025
A golden year of innovative kidney disease therapeuticsMonica Suet Ying Ng, Carmel M Hawley
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 25, 2016
Focus on peritoneal dialysis training: working to decrease peritonitis ratesLei Zhang, Carmel M Hawley, David W Johnson
International Journal of Nephrology|June 5, 2014
Clinical causes of inflammation in peritoneal dialysis patientsYeoungjee Cho, Carmel M Hawley, David W Johnson
Expert Review of Endocrinology & Metabolism|July 31, 2018
An update on bone imaging and markers in chronic kidney diseaseRathika Krishnasamy, Carmel M Hawley, David W Johnson
Nephrology (Carlton, Vic.)|May 15, 2007
Is it time to revisit residual renal function in haemodialysis?Tsun G Ng, David W Johnson, Carmel M Hawley
The New England Journal of Medicine|March 11, 2011
Frequent versus standard hemodialysisSunil V Badve, Carmel M Hawley, David W Johnson
Journal of Medical Case Reports|August 20, 2010
Probable tacrolimus toxicity from tibolone co-administration in a woman: a case reportCarolyn J Clark, Carmel M Hawley, David W Mudge
Nephrology (Carlton, Vic.)|January 29, 2011
Is the problem with the vehicle or the destination? Does high-dose ESA or high haemoglobin contribute to poor outcomes in CKD?Sunil V Badve, Carmel M Hawley, David W Johnson
Pageof 33